학술논문

Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia December 2022 22(12):912-919
Subject
Language
ISSN
2152-2650